Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma-Reference-Cited by-同舟云学术

Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma

Published:2014-02-20 Issue:9 Volume:28 Page:1885-1891
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Corradini P, ,Vitolo U,Rambaldi A,Miceli R,Patriarca F,Gallamini A,Olivieri A,Benedetti F,Todeschini G,Rossi G,Salvi F,Bruno B,Baldini L,Ferreri A,Patti C,Tarella C,Pileri S,Dodero A

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu201479.pdf

Reference34 articles.

1. Foss FM, Zinzani PL, Vose GM, Gascoyne RD, Rosen ST, Tobinai K et al. Peripheral T-cell lymphomas. Blood 2011; 117: 6756–6767.

2. International T cell lymphomas Project. International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: pathology findings and clinical outcomes. J Clin Oncol 2008; 26: 4124–4130.

3. Schmitz N, Trümper L, Ziepert M, Nickelsen M, Ho AD, Metzner B et al. Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group. Blood 2010; 116: 3418–3425.

4. Rodig SJ, Abramson JS, Pinkus GS, Treon SP, Dorfman DM, Dong HY et al. Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H). Clin Cancer Res 2006; 12: 7174–7179.

5. Geissinger E, Bonzheim I, Roth S, Rosenwald A, Muller-Hermelink HK, Rudiger T . CD52 expression in peripheral T-cell lymphomas determined by combine immunophenotyping using tumor cell specific T-cell receptor antibodies. Leuk Lymphoma 2009; 50: 1010–1016.

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimized BEAC conditioning regimen improves clinical outcomes of autologous hematopoietic stem cell transplantation in non-Hodgkin lymphomas;International Journal of Hematology;2024-04-08

2. Allogeneic Hematopoietic Stem Cell Transplantation for Mature T/NK-Cell Lymphomas in Children;Transplantation and Cellular Therapy;2024-04

3. Innovations in Antibody-Drug Conjugate (ADC) in the Treatment of Lymphoma;Cancers;2024-02-18

4. Autologous Stem Cell Transplant in Hodgkin’s and Non-Hodgkin’s Lymphoma, Multiple Myeloma, and AL Amyloidosis;Cells;2023-12-18

5. Allogeneic hematopoetic stem cell transplant for patients with refractory T‐Cell lymphomas;European Journal of Haematology;2023-10-16